Ondek

About:

This company is a private Australian company to develop new medicines by exploiting the immuno-modulatory properties.

Website: http://www.ondek.com

Description:

The company is developing an oral therapeutic candidate, ImmBALANCE®, derived from H. pylori, to treat paediatric allergy – which frequently manifests initially as atopic dermatitis (also known as eczema) and may progress to include food allergies, allergic asthma, allergic rhinitis and other allergic conditions.